224 related articles for article (PubMed ID: 31811153)
41. Optimal reprogramming factor stoichiometry increases colony numbers and affects molecular characteristics of murine induced pluripotent stem cells.
Tiemann U; Sgodda M; Warlich E; Ballmaier M; Schöler HR; Schambach A; Cantz T
Cytometry A; 2011 Jun; 79(6):426-35. PubMed ID: 21548079
[TBL] [Abstract][Full Text] [Related]
42. Generation and characterization of virus-free reprogrammed melanoma cells by the piggyBac transposon.
Yin J; Fan Y; Qin D; Xiaocui Bian X; Bi X
J Cancer Res Clin Oncol; 2013 Sep; 139(9):1591-9. PubMed ID: 23571855
[TBL] [Abstract][Full Text] [Related]
43. OCT4 and SOX2 Work as Transcriptional Activators in Reprogramming Human Fibroblasts.
Narayan S; Bryant G; Shah S; Berrozpe G; Ptashne M
Cell Rep; 2017 Aug; 20(7):1585-1596. PubMed ID: 28813671
[TBL] [Abstract][Full Text] [Related]
44. Induced pluripotency with endogenous and inducible genes.
Duinsbergen D; Eriksson M; 't Hoen PA; Frisén J; Mikkers H
Exp Cell Res; 2008 Oct; 314(17):3255-63. PubMed ID: 18656469
[TBL] [Abstract][Full Text] [Related]
45. Facilitators and impediments of the pluripotency reprogramming factors' initial engagement with the genome.
Soufi A; Donahue G; Zaret KS
Cell; 2012 Nov; 151(5):994-1004. PubMed ID: 23159369
[TBL] [Abstract][Full Text] [Related]
46. Direct Reprogramming of Human Primordial Germ Cells into Induced Pluripotent Stem Cells: Efficient Generation of Genetically Engineered Germ Cells.
Bazley FA; Liu CF; Yuan X; Hao H; All AH; De Los Angeles A; Zambidis ET; Gearhart JD; Kerr CL
Stem Cells Dev; 2015 Nov; 24(22):2634-48. PubMed ID: 26154167
[TBL] [Abstract][Full Text] [Related]
47. Silencing of hepatic fate-conversion factors induce tumorigenesis in reprogrammed hepatic progenitor-like cells.
Serrano F; García-Bravo M; Blazquez M; Torres J; Castell JV; Segovia JC; Bort R
Stem Cell Res Ther; 2016 Jul; 7(1):96. PubMed ID: 27460218
[TBL] [Abstract][Full Text] [Related]
48. Generation of an integration-free induced pluripotent stem cell line (CSC-43) from a patient with sporadic Parkinson's disease.
Marote A; Pomeshchik Y; Goldwurm S; Collin A; Lamas NJ; Pinto L; Salgado AJ; Roybon L
Stem Cell Res; 2018 Mar; 27():82-85. PubMed ID: 29334630
[TBL] [Abstract][Full Text] [Related]
49. In vivo partial reprogramming of myofibers promotes muscle regeneration by remodeling the stem cell niche.
Wang C; Rabadan Ros R; Martinez-Redondo P; Ma Z; Shi L; Xue Y; Guillen-Guillen I; Huang L; Hishida T; Liao HK; Nuñez Delicado E; Rodriguez Esteban C; Guillen-Garcia P; Reddy P; Izpisua Belmonte JC
Nat Commun; 2021 May; 12(1):3094. PubMed ID: 34035273
[TBL] [Abstract][Full Text] [Related]
50. Regulatable adenovector harboring the GFP and Yamanaka genes for implementing regenerative medicine in the brain.
Lehmann M; Canatelli-Mallat M; Chiavellini P; Morel GR; Reggiani PC; Hereñú CB; Goya RG
Gene Ther; 2019 Nov; 26(10-11):432-440. PubMed ID: 30770896
[TBL] [Abstract][Full Text] [Related]
51. MBD3 inhibits formation of liver cancer stem cells.
Li R; He Q; Han S; Zhang M; Liu J; Su M; Wei S; Wang X; Shen L
Oncotarget; 2017 Jan; 8(4):6067-6078. PubMed ID: 27894081
[TBL] [Abstract][Full Text] [Related]
52. Generation of iPS cells using a BacMam multigene expression system.
Takata Y; Kishine H; Sone T; Andoh T; Nozaki M; Poderycki M; Chesnut JD; Imamoto F
Cell Struct Funct; 2011; 36(2):209-22. PubMed ID: 21979235
[TBL] [Abstract][Full Text] [Related]
53. Reprogramming Factors Remodel Melanoma Cell Phenotype by Changing Stat3 Expression.
Wang Y; Mou Y; Zhang H; Wang X; Li R; Cheng Z; Liu X
Int J Med Sci; 2017; 14(13):1402-1409. PubMed ID: 29200954
[TBL] [Abstract][Full Text] [Related]
54. Artificial acceleration of mammalian cell reprogramming by bacterial proteins.
Ikeda T; Uchiyama I; Iwasaki M; Sasaki T; Nakagawa M; Okita K; Masui S
Genes Cells; 2017 Oct; 22(10):918-928. PubMed ID: 28776863
[TBL] [Abstract][Full Text] [Related]
55. Transcriptional Control of Somatic Cell Reprogramming.
Xu Y; Zhang M; Li W; Zhu X; Bao X; Qin B; Hutchins AP; Esteban MA
Trends Cell Biol; 2016 Apr; 26(4):272-288. PubMed ID: 26776886
[TBL] [Abstract][Full Text] [Related]
56. The nuclear receptor Nr5a2 can replace Oct4 in the reprogramming of murine somatic cells to pluripotent cells.
Heng JC; Feng B; Han J; Jiang J; Kraus P; Ng JH; Orlov YL; Huss M; Yang L; Lufkin T; Lim B; Ng HH
Cell Stem Cell; 2010 Feb; 6(2):167-74. PubMed ID: 20096661
[TBL] [Abstract][Full Text] [Related]
57. Reprogramming bladder cancer cells for studying cancer initiation and progression.
Iskender B; Izgi K; Canatan H
Tumour Biol; 2016 Oct; 37(10):13237-13245. PubMed ID: 27456363
[TBL] [Abstract][Full Text] [Related]
58. Gata4 blocks somatic cell reprogramming by directly repressing Nanog.
Serrano F; Calatayud CF; Blazquez M; Torres J; Castell JV; Bort R
Stem Cells; 2013 Jan; 31(1):71-82. PubMed ID: 23132827
[TBL] [Abstract][Full Text] [Related]
59. Sox2 and Klf4 as the Functional Core in Pluripotency Induction without Exogenous Oct4.
An Z; Liu P; Zheng J; Si C; Li T; Chen Y; Ma T; Zhang MQ; Zhou Q; Ding S
Cell Rep; 2019 Nov; 29(7):1986-2000.e8. PubMed ID: 31722212
[TBL] [Abstract][Full Text] [Related]
60. Derivation of LIF-independent mouse iPS cells with modified Oct4.
Hirai H; Firpo M; Kikyo N
Stem Cell Res; 2015 Sep; 15(2):384-6. PubMed ID: 26318720
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
